
[Federal Register Volume 88, Number 160 (Monday, August 21, 2023)]
[Notices]
[Page 56844]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-18009]



[[Page 56844]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Statement of Organization, Functions, and Delegations of 
Authority

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
entitled ``Statement of Organization, Functions, and Delegations of 
Authority'' that appeared in the Federal Register of August 14, 2023. 
The document announced amendments to the organization structure for 
FDA, Center for Devices and Radiological Health (CDRH), Office of 
Strategic Partnerships and Technology Innovation (OST). Although HHS 
approved these amendments on June 27, 2023, the Notice inadvertently 
omitted to include the following language: ``FDA will not implement the 
new organizational structure until after the necessary requirements are 
completed.'' This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Denise Huttenlocker, Associate 
Director for Management, Office of Management, Center for Devices and 
Radiological Health, Food and Drug Administration, Bldg. 66, 10903 New 
Hampshire Ave., Silver Spring, MD 20993, 240-743- 1760.

SUPPLEMENTARY INFORMATION: In the Federal Register of August 14, 2023 
(88 FR 55053), in FR Doc. 2023-17379, the following corrections are 
made:
    1. On page 55053, in the second column, in the Dates section, after 
the first sentence, add ``FDA will not implement the new organizational 
structure until after the necessary requirements are completed.''
    2. On page 55053, in the third column, in section III., remove the 
first sentence and add in its place, ``After completion of the 
necessary requirements for implementation, this reorganization will be 
reflected in FDA's Staff Manual Guide (SMG).''

    Dated: August 17, 2023.
Elizabeth J. Gramling,
Executive Secretary to the Department, Department of Health and Human 
Services.
[FR Doc. 2023-18009 Filed 8-17-23; 4:15 pm]
BILLING CODE 4164-01-P


